Real world outcomes for treatment of diffuse large B cell Lymphoma in patients aged 80 and over

被引：0
|
作者：
Cooke, R. [1 ]
Williams, C. [2 ]
Holmes, G. [2 ]
机构：
[1] Northumbria Healthcare NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Northumbria Healthcare NHS Trust, Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [41] Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
    Chien, Hsu-Chih
    Morreall, Deborah
    Patil, Vikas
    Rasmussen, Kelli M.
    Li, Chungyang
    Yong, Christina M.
    Burningham, Zachary
    Masaquel, Anthony
    Halloran, Mary
    De Long-Sieg, Elisha
    Schulz, Mathias
    Sauer, Brian C.
    Halwani, Ahmad S.
    FUTURE ONCOLOGY, 2020, 17 (04) : 411 - 422
  • [42] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562
  • [43] REAL-WORLD SAFETY AND EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA.
    Wang, M.
    Datta, D.
    Rubin, B.
    Patel, A.
    Vashisht, R.
    Belov, A.
    Whitaker, B.
    Anderson, S.
    Butte, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S50 - S50
  • [44] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [45] Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma
    Kim, Dae Wook
    Byun, Ja Min
    Lee, Jeong-Ok
    Kim, Jae Kyoung
    Koh, Youngil
    JCI INSIGHT, 2023, 8 (02)
  • [46] Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
    Tove Wästerlid
    Sverker Hasselblom
    Joel Joelsson
    Caroline E. Weibull
    Georgios Rassidakis
    Birgitta Sander
    Karin E. Smedby
    Blood Cancer Journal, 11
  • [47] Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
    Wasterlid, Tove
    Hasselblom, Sverker
    Joelsson, Joel
    Weibull, Caroline E.
    Rassidakis, Georgios
    Sander, Birgitta
    Smedby, Karin E.
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [48] CAR-T Therapy in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Real World Outcomes Based on Tumor Biology
    Brinkman, Luke
    Wagner, Charlotte B.
    Ying, Jian
    Fraga, Martina
    Marini, Bernard L.
    Scappaticci, Gianni Bruno
    Ptachcinski, Jonathan
    Patel, Sagar S.
    BLOOD, 2022, 140 : 9546 - 9547
  • [49] Analysis of clinical presentation and prognosis of diffuse large B-cell lymphoma in patients over 80 years of age
    Lee, Shin
    Negoro, Eiju
    Oiwa, Kana
    Fujita, Kei
    Ookura, Miyuki
    Matsuda, Yasufumi
    Tai, Katsunori
    Hosono, Naoko
    Ueda, Takanori
    Yamauchi, Takahiro
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Patterns of Care of Diffuse Large B Cell Lymphoma Patients 80 Years and Older: Worse Outcomes after Treatment without Increased Relapse
    Keenan, Madison
    Boughan, Kirsten Marie
    Cooper, Brenda
    Gallogly, Molly M.
    Gerson, Stanton L.
    Lazarus, Hillard M.
    Malek, Ehsan
    Metheny, Leland
    Otegbeye, Folashade
    Tomlinson, Benjamin K.
    Moore, Erika
    Oduro, Kwadwo Asare
    Beck, Rose
    Meyerson, Howard
    de Lima, Marcos
    Caimi, Paolo F.
    BLOOD, 2018, 132
12345